| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/20/2008 | US7375248 Inhibitors of matrix metalloproteinase |
| 05/20/2008 | US7375205 Elongase genes and uses thereof |
| 05/20/2008 | US7375136 Such as 1-(4-methanesulphonamidepheoxy)3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol; synthesis; effective against brain and/or spinal cord tissue acidification disorders |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375110 Nicotinic cholinergic receptors modulators; pain, neurodegenerative diseases; neurotransmission dysfuctions; central and autonomic nervous systems disorders; 1'-(3-pyridyl)-spiro[1-azabicyclo[2.2.1]heptane-2,3'-pyrrolidine] |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | US7375102 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 05/20/2008 | US7375094 Produced via Streptomyces; antitumor agents; time-release agents; for opiod-resistant pain; drug screening |
| 05/20/2008 | US7374937 in vitro methods of inducing proliferation of stromal cells without inducing differentiation of mesenchymal stem cells; use in gene therapy and transplantation; initial density of isolated cells is less than 50 cells per sq cm of growth surface, incubating; contacting cells with antibody to Lipocortin II |
| 05/20/2008 | US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay |
| 05/20/2008 | US7374769 Method for treating a trigeminal neuralgia by peripheral administration of a neurotoxin |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2430065C Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 05/20/2008 | CA2322309C Quinolin-4-yl derivatives |
| 05/20/2008 | CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1" |
| 05/20/2008 | CA2199664C Novel prodrugs for the therapy of tumors and inflammatory disorders |
| 05/15/2008 | WO2008058034A1 Methods of treating dermatological disorders or conditions |
| 05/15/2008 | WO2008057859A2 Modulators of glucocorticoid receptor, ap-i and/or nf-kappab activity and use thereof |
| 05/15/2008 | WO2008057857A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF |
| 05/15/2008 | WO2008057856A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| 05/15/2008 | WO2008057681A2 Thiophene compounds |
| 05/15/2008 | WO2008057511A2 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 05/15/2008 | WO2008057246A2 Method for treating inflammatory disorders |
| 05/15/2008 | WO2008057136A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/15/2008 | WO2008056898A1 Caspase inhibitors based on pyridazinone scaffold |
| 05/15/2008 | WO2008056634A1 Novel hydroxyindole derivative |
| 05/15/2008 | WO2008056156A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | WO2008056118A1 N-aryl-hydroxyalkylidene-carboxamide compounds and their use |
| 05/15/2008 | WO2008055959A1 Novel compounds useful for the treatment of degenerative & inflammatory diseases |
| 05/15/2008 | WO2008055945A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| 05/15/2008 | WO2008055842A1 Substituted 6-phenyl-pyrido [2,3-d] pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same |
| 05/15/2008 | WO2008055710A1 Indole and indazole derivatives as anti-inflammatory agents |
| 05/15/2008 | WO2008055709A1 Indazole and indole derivatives as anti -inflammatory agents |
| 05/15/2008 | WO2008029237A3 Combination therapies for rheumatoid arthritis |
| 05/15/2008 | WO2008015538A3 Use of diaza- and thiaza-cycloalkanediones for preventing and/or treating pain and /or migraine |
| 05/15/2008 | WO2008011487A3 L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain |
| 05/15/2008 | US20080114285 Energy-activated targeted cancer therapy |
| 05/15/2008 | US20080114057 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 05/15/2008 | US20080114031 1,2;5,6-Di-O-isopropylidene-3-deoxy-3-[{(4-chloro-phenyl)amino}-carbonyl]-amino- alpha -D-allofuranoside; |
| 05/15/2008 | US20080114025 Inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures; use of ADP receptor antagonist and a thromboxane A2 receptor antagonist |
| 05/15/2008 | US20080114024 such as 5-(3-Aminopropylamino)-2-benzyloxy-7-(4-methoxyphenyl)-[1,6]naphthyridine; spleen tyrosine kinase inhibitor; controlling activation of mast cells; antiallergens, antiinflamamtory agents; asthma, chronic obstructive pulmonary disease (COPD), Crohn's disease, bronchitis, conjunctivitis, psoriasis |
| 05/15/2008 | US20080114015 NF-kB inhibitors and uses thereof |
| 05/15/2008 | US20080114003 Pyrimidinylisoxazole Derivatives |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113973 Pharmaceutical composition in unit dose form which contains a COX-2 inhibitor and a thromboxane A2 receptor antagonist; for treatment of pain or inflammation; less risk of inducing adverse cardiovascular effects than when COX-2 inhibitors are administered alone |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113956 Substituted Porphyrins |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic |
| 05/15/2008 | US20080113014 Method for Screening for Compounds Safe for Gastric Mucosa |
| 05/15/2008 | CA2669038A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | CA2669019A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/15/2008 | CA2668731A1 Kinase inhibitors and methods for using the same |
| 05/15/2008 | CA2668414A1 Methods of treating dermatological disorders or conditions |
| 05/15/2008 | CA2668282A1 Caspase inhibitors based on pyridazinone scaffold |
| 05/15/2008 | CA2668134A1 Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 05/15/2008 | CA2666306A1 4-1 bb ligand in inflammatory diseases |
| 05/14/2008 | EP1921078A1 Multikinase inhibitor |
| 05/14/2008 | EP1921068A1 Indazole and indole derivatives as anti-inflammatory agents |
| 05/14/2008 | EP1921067A1 Indole and indazole derivatives as anti-inflammatory agents |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1920772A1 Prophylactic and/or therapeutic method for rheumatoid arthritis |
| 05/14/2008 | EP1919954A2 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 05/14/2008 | EP1919947A1 Therapeutically active alpha-msh analogues |
| 05/14/2008 | EP1919919A1 Pyridazinone derivatives used for the treatment of pain |
| 05/14/2008 | EP1919914A2 P38 map kinase inhibitors and methods for using the same |
| 05/14/2008 | EP1919877A1 P38 map kinase inhibitors and methods for using the same |
| 05/14/2008 | EP1919471A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 05/14/2008 | EP1919470A1 FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS |
| 05/14/2008 | EP1771425B1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 05/14/2008 | EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds |
| 05/14/2008 | EP1355636B1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 05/14/2008 | EP1309355B1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | CN101180267A Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 05/14/2008 | CN101180063A Phospholipids for use in the treatment of an allergic inflammatory condition |
| 05/14/2008 | CN101180047A Use of cyclodextrin complexes containing lipoic acid |
| 05/14/2008 | CN101180045A Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands |
| 05/14/2008 | CN101176790A Percutaneous absorption fortifier |
| 05/14/2008 | CN101176768A Epityphlon health |
| 05/14/2008 | CN101176767A Improved preparation of traditional Chinese medicine preparation for curing rheumatic |
| 05/14/2008 | CN101176753A Proprietary Chinese medicine for curing arthralgia due to wind-cold-dampness |
| 05/14/2008 | CN101176750A Chaihuang freeze dried injection and preparation method thereof |
| 05/14/2008 | CN101176749A Chaihuang freeze dried injection and preparation method thereof |
| 05/14/2008 | CN101176741A Hydroxypropyl-beta-cyclodextrin clathrate, preparing method and application of radix bupleuri volatile oil |
| 05/14/2008 | CN101176740A Method for extracting angelica essential oil |
| 05/14/2008 | CN101176736A Medicine gas for curing rheumatism |
| 05/14/2008 | CN101176724A Oxymatrine or matrine sustained-release pellet and preparation method thereof |
| 05/14/2008 | CN101176722A Scutellaria glycosides freeze dried injection solution and preparation method thereof |
| 05/14/2008 | CN100387703C Fatly phospho embrella Pa-I.H bacterial strain and method of culturing fatty phospho embrella and medicine made from its active component |
| 05/14/2008 | CN100387623C Connexin transduction structural domain and bioactive protein of auxiliary protein, its production and use |
| 05/14/2008 | CN100387602C Chelerythrine compound and its preparing method |
| 05/14/2008 | CN100387598C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 05/14/2008 | CN100387576C Substituted phenylalkanoic acid derivatives and use thereof |
| 05/14/2008 | CN100387295C Wanhua oil Babu plaster for traumatic injury and preparing method |
| 05/14/2008 | CN100387285C Refining method for caoshanhu by menbrane technology separation |